First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany.
QJM. 2019 May 1;112(5):355-362. doi: 10.1093/qjmed/hcz033.
Takotsubo Syndrome (TTS) is an acute reversible left ventricular dysfunction. Recently published studies have highlighted a similar mortality rate as acute coronary syndrome (ACS). We compared the impact of gender differences on the outcome of TTS patients as compared to ACS patient.
We included a collective of 138 patients TTS between 2003 and 2016 at our institution. Patients were divided according to their gender into two groups (Males n=21, 15% and females, n=117, 85%). They were compared with a cohort of 300 patients with a diagnosis of ACS.
On the acute phase, in male patients with TTS, a treatment with inotropic was more often required (33.3 vs. 11.5%, P<0.01), were more susceptible to cardiogenic shock (28.6 vs. 12.5%, P<0.04). Concerning the long-term prognosis after the acute event, male patients had higher all-cause mortality over long-term follow-up. A Kaplan-Meier analysis indicated that the mortality of male patients with TTS was significantly higher compared to male patients with ACS (log-rank <0.01), while there was no significant difference between female patients with TTS and ACS (log-rank =0.60, P=0.45). In a multivariate cox regression analysis, male gender (HR 2.7, 95% CI: 1.1-6.5, P=0.02) GFR <60 ml/min (HR 2.8, 95% CI: 1.2-6.0, P=0.01) and history of cancer (HR 3.6, 95% CI 1.4-9.3, P<0.01) were independent predictors of 5-year mortality.
Considerable evidence suggests that TTS compared to ACS implicates more significant clinical short-term events on male patients and it may be associated with poorer long-term prognosis.
Takotsubo 综合征(TTS)是一种急性可逆性左心室功能障碍。最近发表的研究强调了与急性冠状动脉综合征(ACS)相似的死亡率。我们比较了性别差异对 TTS 患者与 ACS 患者结局的影响。
我们在机构中纳入了 2003 年至 2016 年间的 138 例 TTS 患者。根据性别将患者分为两组(男性 21 例,占 15%,女性 117 例,占 85%)。将他们与一组 300 例 ACS 诊断患者进行比较。
在急性阶段,TTS 男性患者更常需要使用正性肌力药物(33.3% vs. 11.5%,P<0.01),更易发生心源性休克(28.6% vs. 12.5%,P<0.04)。关于急性事件后的长期预后,TTS 男性患者在长期随访中有更高的全因死亡率。Kaplan-Meier 分析表明,与 ACS 男性患者相比,TTS 男性患者的死亡率明显更高(对数秩检验<0.01),而 TTS 女性患者与 ACS 女性患者之间无显著差异(对数秩检验=0.60,P=0.45)。在多变量 Cox 回归分析中,男性(HR 2.7,95%CI:1.1-6.5,P=0.02)、肾小球滤过率<60 ml/min(HR 2.8,95%CI:1.2-6.0,P=0.01)和癌症史(HR 3.6,95%CI 1.4-9.3,P<0.01)是 5 年死亡率的独立预测因素。
大量证据表明,与 ACS 相比,TTS 在男性患者中涉及更多严重的短期临床事件,可能与较差的长期预后相关。